Challenge
Chemotherapy regimen and dosing logic is complex and safety-critical.
Agnotic approach
We build protocol-driven regimen support with dosing checks and human-in-the-loop review.
Oncology Software Solutions
Oncology software development
Cancer care runs on regimens, staging and genomic results that general EHR screens handle poorly. Agnotic builds oncology software that keeps them structured, checked and connected.
HIPAA-ReadyFHIR R4Audit LoggedInteroperable
Trusted by global innovators
What is oncology software development?
Oncology software development is building the systems a cancer practice relies on: regimen ordering with dose checks, structured staging and biomarkers, infusion scheduling, tumor board preparation and trial matching. Agnotic Technologies builds them for oncology practices, cancer centers and precision oncology startups, connected to your oncology EHR through HL7 FHIR.
Oncology software has to model complex, protocol-driven care (chemotherapy regimens, TNM staging, molecular markers, and clinical-trial eligibility), where a small error carries real clinical weight.
We build the regimen logic, structured staging, and trial-matching oncology needs, integrated with the EHR and genomics data, with safety and PHI handling engineered in.
Oncology platform architecture
A oncology platform (clinical workflow, icd-o / tnm cancer staging, and connected integrations) with PHI handled to HIPAA standards at every layer.
The problem
Why is oncology software hard to get right?
Off-the-shelf products rarely fit oncology. Here is where they fall short, and how we build around it.
Challenge
Trial eligibility and molecular data are scattered across systems.
Agnotic approach
We build trial-matching against structured staging and genomic markers pulled from the EHR and lab feeds.
Challenge
Staging and outcomes data are unstructured and hard to report.
Agnotic approach
We capture TNM/ICD-O staging as structured data so reporting and analytics are possible.
What oncology software do we build?
A oncology capability set engineered for its real workflows, codes, and devices.
Regimen & protocol support
Protocol-driven chemotherapy regimen logic with dosing checks and safety guardrails.
Structured staging
TNM and ICD-O staging captured as structured, reportable data.
Clinical-trial matching
Eligibility matching against staging and molecular markers from the EHR and labs.
Genomics & lab integration
Molecular and lab result ingestion tied to the patient record.
Infusion & scheduling
Infusion-chair scheduling and care-plan orchestration across the cancer center.
Oncology EHR integration
Integration with oncology EHRs and the enterprise record via FHIR/HL7.
Where it fits
Who needs oncology software development?
Oncology practices, cancer centers, and precision-oncology startups.
Practices & health systems
Oncology groups modernizing clinical and administrative workflows.
Digital health startups
Oncology-focused products going to market.
MedTech & device makers
Oncology device companions, data pipelines, and companion apps.
Payers & programs
Oncology programs, care management, and value-based initiatives.
Engineered for oncology
Oncology practices, cancer centers, and precision-oncology startups choose us because we build oncology software that fits the workflow, not the other way round.
Protocol-driven
Regimen and staging logic built safety-first
Interoperable
FHIR R4, HL7 v2, and SMART on FHIR by default
MVP-ready
Core oncology workflow shipped first, then scaled
Compliance-First Healthcare App Development Services Backed by Global Standards
15-Minute Scoping Call01
HIPAA
Health Insurance Portability and Accountability Act
Protect PHI with privacy-first architecture, encrypted storage and transmission, strict access controls, and traceable audit logs.
02
GDPR
General Data Protection Regulation
Implement lawful consent flows, data minimization, retention controls, and secure processing for sensitive health data.
03
FHIR
Fast Healthcare Interoperability Resources
Enable standardized health data exchange across apps, care teams, and systems through standards-based FHIR APIs.
04
HL7
Health Level Seven International
Support enterprise-grade interoperability with HL7-based integrations for records, events, and clinical messaging workflows.
05
HITRUST
Health Information Trust Alliance
Align security programs to healthcare-specific control and risk management practices trusted by providers and ecosystem partners.
06
HITECH
Health Information Technology for Economic and Clinical Health Act
Design with breach notification readiness, digital record safeguards, and operational controls that support regulated care programs.
07
SaMD
FDA Software as a Medical Device
Plan software quality, traceability, and documentation pathways for products that may require SaMD review and submission.
08
MDR (EU)
Medical Device Regulation (European Union)
Prepare EU market-ready processes for risk classification, evidence tracking, and lifecycle governance under MDR expectations.
09
SAMHSA
Substance Abuse and Mental Health Services Administration
Apply confidentiality controls and consent-aware sharing models for behavioral and mental health data experiences.
Codes, standards & devices
Oncology codes and data standards
ICD-OFHIRHL7
Our Process
How does Agnotic build oncology software?
We prove the core workflow with real users before scaling: clinical fit and adoption decide the outcome.
1.
Discovery & Clinical Design
We map the oncology workflow, the codes and devices involved, and the core job to be done.
Workflow-shaped
2.
Architecture & Core Build
We build the core workflow with interoperability and PHI handling engineered in from the start.
Safeguards built in
3.
Integrations
EHR, device, and standards integration so the product connects to the systems already in use.
Connected
4.
Launch & Iterate
A measured launch tracking adoption and outcomes, then iteration.
Adoption-tuned
Facts and sources
Which data standards shape oncology software?
Short facts we design oncology data, EHR access and security around, each linked to its primary source.
mCODE (minimal Common Oncology Data Elements) is an HL7 FHIR R4 implementation guide that assembles a core set of structured data elements for oncology EHRs, in about 40 profiles grouped into patient information, disease characterization, health assessment, genomics, cancer treatments and outcomes.
Source: HL7 FHIR mCODE Implementation Guide (HL7)HHS adopts the United States Core Data for Interoperability (USCDI) as the standard set of health data classes and data elements for certified health IT.
Source: 45 CFR 170.213 (eCFR)ONC certification criterion 170.315(g)(10) requires certified EHRs to offer a standardized API for patient and population services based on HL7 FHIR.
Source: 45 CFR 170.315 (eCFR)The HIPAA Security Rule requires administrative, physical and technical safeguards for electronic protected health information.
Source: 45 CFR Part 164 Subpart C (eCFR)
Why Partner With Us
15-Minute Scoping CallWhy do cancer centers build with Agnotic?
Healthcare-only focus, standards-based engineering, and delivery you can hold to account.
Oncology workflow depth
We understand the oncology workflow, the codes and devices, and the clinical realities that decide adoption.
Compliance by default
HIPAA safeguards and role-based access designed in from the first commit, not retrofitted before launch.
Interoperable engineering
FHIR R4, HL7 v2, DICOM, and SMART on FHIR so what we build connects to your existing systems.
Delivery you can verify
Clear scope, working software early, and accountability throughout the engagement.
Frequently Asked Questions
Yes. We model regimens as ordered cycle-day templates with BSA and carboplatin AUC (Calvert) dosing, cumulative anthracycline and bleomycin caps, and renal or hepatic dose adjustments. Orders enforce pre-medication, hydration, and lab gating before a nurse can release a cycle.
We aggregate pathology, radiology (RECIST 1.1 measurements), staging, and molecular reports into a single tumor-board view, track case agendas and multidisciplinary recommendations, and write the consensus plan back to the chart as a discrete note for the treating oncologist.
Yes. We interface with OncoEMR and Elekta MOSAIQ via HL7 and FHIR, and generate NAACCR-formatted abstracts for state and hospital cancer registries. AJCC 8th-edition staging elements are captured discretely so registry reporting does not require chart re-abstraction.
We store AJCC TNM stage with restaging events, and structure biomarkers like ER/PR/HER2, EGFR, ALK, PD-L1, and MSI. Next-generation sequencing reports map to actionable variants, linking targeted-therapy eligibility and clinical-trial matching directly to the patient record.
Often, yes. We build modules such as tumor board preparation, trial matching or a patient symptom app beside your oncology EHR, read and write data through its HL7 or FHIR interfaces, and map cancer data to mCODE profiles where both sides support them.
Yes. A patient app can collect symptoms and side effects between cycles, show the infusion schedule and route severe reports to nurse triage under rules your clinicians set.
Buy when a packaged oncology EHR covers your regimens and infusion workflow. Build when you need something it does not do well, such as research data capture, trial matching or a patient-facing app, and connect it to the record you keep.
It depends on the first workflow (regimen support, staging capture, tumor boards or trial matching), the safety review it needs, and which EHR, lab and genomics feeds it connects to. We give you a timeline after the scoping call.
Yes. The first release is scoped to one workflow, such as tumor board preparation for one disease team, before regimen support, trial matching and other teams are added.
Ready to build your oncology software?
Tell us your oncology workflow and goals. We'll return a plan that's clinically credible, interoperable, and built to ship.
contact@agnotic.com
Partnerships
contact@agnotic.com